Pharmacoepidemiology
Author(s)
Bibliographic Information
Pharmacoepidemiology
Churchill Livingstone, 1989
Available at 4 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographies and index
Description and Table of Contents
Description
This is a survey of the application of the principles of epidemiology to clinical pharmacology. As well as providing background information on what is included in this field, it also describes the systems developed to perform pharmcoepidemiologic studies.
Table of Contents
- Part 1: What is pharmacoepidemiology?
- study designs available for pharmacoepidemiology studies
- when should one perform pharmacoepidemiology studies. Part 2 Perspectives on pharmacoepidemiology: the view from academia
- pharmacoepidemiology - the view from academia
- pharmacoepidemiology - the view from industry
- pharmacoepidemiology - the view from a regulatory agency
- pharmacoepidemiology - the view from a US court room. Part 3 Systems available for pharmacoepidemiology studies: spontaneous reporting system in the US
- spontaneous reporting systems outside the US
- intensive hospital-based cohort studies
- group health cooperative of Puget sound
- Kaiser permanente medical care program - northern California and other regions
- medicaid data bases
- health data bases in Saskatchewan
- the Rhode island drug use reporting scheme
- inpatient data bases
- other approaches to ppharmacoepidemiology studies
- how should one perform pharmacoepidemiology studies? Part 4 Selected methodologic issues in pharmacoepidemiology: studies of drug utilization
- determining causation from case reports
- screening for unknown effects of newly-marketed drugs
- the use of pharmacoepidemiology to study benefical drug effects
- application of health economics to the study of drug effects
- using epidmiologic methods to individualize drug therapy. Part 5 Conclusion: the future of pharmacoepidemiology.
by "Nielsen BookData"